publicações selecionadas
-
artigo académico
- NAD+ reverses Alzheimer’s neurological deficits via regulating differential alternative RNA splicing of EVA1C. Science Advances. 2025
- RNA Granules at the Crossroads of Synaptic Dysfunction and Neurodegeneration. Journal of Neurochemistry. 2025
- Screening of novel ASOs against Tau protein - shifting isoforms. Molecular Therapy. 2024
-
documento
- The therapeutic potential of TUDCA in stress-related brain pathologies 2025
- The therapeutic potential of TUDCA in stress-related depression 2025
- Therapeutic potential of mTOR inhibitor - Torisel – for the clearance of Tau accumulation and RNA-protein granules in stress and Alzheimer’s Disease pathologies 2025
- The therapeutic potential of tauroursodeoxycholic acid in stress-related brain pathologies 2025
- Therapeutic potential of mTOR inhibitor – Torisel - against stress and Alzheimer’s Disease pathologies 2025
- Therapeutic potential of mTOR inhibitor – Torisel - against stress and Alzheimer’s Disease pathologies 2024
- Therapeutic potential of mTOR inhibitor for the clearance of Tau accumulation and RNA-protein granules in stress and Alzheimer’s Disease pathologies 2024
- Antisense oligonucleotide (ASOs) therapeutic approach against Tau-driven neuronal pathology in Alzheimer's disease brain pathology. 2023
- Therapeutical potential of tauroursodeoxycholic acid in stress-related brain pathologies 2023
-
teses